North America - Jan/Feb 2020

  • Canada: New Medical Devices Directorate established at Health Canada

  • Canada: Final guidance published on Software as a Medical Device (SaMD)

  • USA: Stephen Hahn takes over as FDA Commissioner

  • USA: President Trump repeals medical device excise tax

  • USA: US Court disagrees with FDA’s classification of a device as a drug

  • USA: New rules for cranial electrotherapy stimulator devices for treating anxiety and/or insomnia, and for treating depression

  • USA: Orthopaedic surgical instrumentation designed for osteochondral implants with press-fit fixation classified as Class II (special controls)

  • USA: Class II classification appropriate for internal therapeutic massagers

  • USA: Class II classification for radiological CADx software for lesions suspicious for cancer

  • USA: Radiological computer aided triage and notification software has been classified into Class II (special controls)

  • USA: Reclassification of medical image analysers, including CADe devices

  • USA: Class II classification deemed appropriate for self-fitting air-conduction hearing aids

  • USA: Exemption from pre-market notification for powered wheeled stretchers

  • USA: List of Class I and Class II devices exempt from pre-market notification

  • USA: Five types of Class II devices proposed for exemption from 510(k) requirements

  • USA: Continuous glucose monitor data management systems classified into Class I

  • USA: All pre-market applications now require only a single submission in electronic format

  • USA: Guidance outlines process for seeking a review of a denial of a CFG

  • USA: Performance criteria proposed for MR coils to support Safety and Performance Based Pathway

  • USA: Requesting FDA feedback on combinations products – draft guidance circulated for comment

  • USA: Guidance drafted on 510(k) submissions for peripheral percutaneous transluminal angioplasty and specialty catheters

  • USA: Guidance drafted on bridging for drug-device and biologic-device combination products

  • USA: FDA’s regulatory agenda for 2020

  • USA: CDRH announces new steps to advance innovation in device sterilisation using EtO

  • USA: FDA recognises more than 100 new standards, including ISO 14971: 2019


Click here for the full article on Global Regulatory Press.

Contact us at info@arqon.com

0 views
  • LinkedIn - White Circle
  • YouTube - White Circle
  • Twitter - White Circle
  • LinkedIn - White Circle
  • YouTube - White Circle
  • Twitter - White Circle

Services

Contacts

Call us:

   : +65 6909 0396

   : +65 9067 1432

 

Email us: info@arqon.com

Resources

© 2020 ARQon All Rights Reserved. 

  • LinkedIn - White Circle
  • YouTube - White Circle
  • Twitter - White Circle